Assessing the Expected Costs of Continuous Remote Monitoring for Post-Discharge Home Use and the Readmission Reduction Required to Achieve Cost Neutrality. - Larsen AT; Sopina L; Aasvang EK; Meyhoff CS; Kristensen SR; Kjellberg J (PharmacoEconomics - open, 2026)